
Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community‐acquired methicillin‐resistant Staphylococcus aureus
Author(s) -
Farley Jason E.
Publication year - 2008
Publication title -
journal of the american academy of nurse practitioners
Language(s) - English
Resource type - Journals
eISSN - 1745-7599
pISSN - 1041-2972
DOI - 10.1111/j.1745-7599.2007.00290.x
Subject(s) - medicine , epidemiology , intensive care medicine , methicillin resistant staphylococcus aureus , cinahl , medline , staphylococcal skin infections , staphylococcus aureus , nursing , psychological intervention , biology , bacteria , genetics , political science , law
Purpose: This article reviews the evolving epidemiology of community‐acquired methicillin‐resistant Staphylococcus aureus (CA‐MRSA) and the appropriate outpatient management of CA‐MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed. Data Sources: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966–2006). Conclusions: The epidemiology of CA‐MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high‐risk populations and within families is urgently needed. Implications for Practice: Nurse practitioners must remain informed of the epidemiology of common and emerging drug‐resistant organisms in their patient populations.